A Recent FDA PRP Study

Published on September 27th, 2018

Did you know that the FDA was involved in a PRP study? This is great news! While PRP has proven to be an extremely beneficial pain reducer for a number of orthopedic problems, it is still considered “experimental.” Just like many medications that are currently used “off-label,” such as: Botox for wrinkles, Coumadin for heart disease, or Singulair for COPD, PRP is also used “off-label” when injected for pain relief. Unlike the above-mentioned pharmaceuticals, however, PRP comes from your own cells to help your body cope with pain and orthopedic conditions naturally.

Therefore, it is very exciting that the FDA was involved in Dr. Smith’s clinical trial comparing PRP to saline placebo injections. The study, Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial, concludes that patients who received PRP injections had quantifiable pain relief and functional improvement over the patients who received saline placebo injections. After a year, patients who received PRP injections had pain scores that improved by 78% vs. only a 7% improvement in the placebo group.

If you are interested in PRP injections and would like more information about how this treatment might help you, call Gitelis Orthopedics!

Back to News

Office Location

Gitelis Orthopedics office

Hoffman Estates

1800 McDonough Road
Suite 202
Hoffman Estates, IL 60192

Located in the Ashton Center for Day Surgery building.

(847) 807-7770
fax: (847) 807-7771

Download Patient Forms


27401 W. Hwy 22
Suite #6
Barrington, Il. 60010

Second office near Good Shepherd Hospital in Barrington, Il.

(847) 807-7770
fax: (847) 807-7771

Download Patient Forms